Multiple sclerosis (MS) is most prevalent in Northern Europe and Canada, and more common in the northernmost latitudes. In ...

Scientists have identified a novel molecular pathway that may link salt intake to MS risk. Ina Peters/Stocksy The study also found that higher dietary salt intake activates this molecular pathway in ...

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory small molecule therapy that can cross the blood-brain barrier may be attractive ...

A biological, mechanism-based framework to reclassify multiple sclerosis (MS) types was proposed by the International Advisory Committee on Clinical Trials in Multiple Sclerosis. The approach lays the ...

More than two decades ago, a research team discovered a type of T cell in humans that suppresses the immune system; they later found that these so-called regulatory T cells, when defective, are an ...

Scientists studying animals at high altitudes discovered a previously unknown mechanism that is key for regulating myelin ...

Researchers have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has ...

Multiple sclerosis (MS) is a debilitating inflammatory autoimmune disease that affects the central nervous system (CNS). While sufferers can experience long periods of remission where common symptoms ...

Multiple sclerosis (MS) is a chronic autoimmune disease caused by the interaction between environmental factors, such as high dietary salt intake, and genetic risk factors. When regulatory T cells, ...